000117166 001__ 117166
000117166 005__ 20240319080958.0
000117166 0247_ $$2doi$$a10.1186/s12888-022-03800-x
000117166 0248_ $$2sideral$$a128422
000117166 037__ $$aART-2022-128422
000117166 041__ $$aeng
000117166 100__ $$aCastilla, Diana
000117166 245__ $$aEcological momentary intervention to enhance emotion regulation in healthcare workers via smartphone: a randomized controlled trial protocol
000117166 260__ $$c2022
000117166 5060_ $$aAccess copy available to the general public$$fUnrestricted
000117166 5203_ $$aBackground: CUIDA-TE is an APP that offers transdiagnostic cognitive behavioral therapy focused on enhancing emotion regulation. As a novelty, it incorporates ecological momentary interventions (EMI), which can provide psychological support in real time, when suffering arises. The main goal of the study is to evaluate the efficacy of CUIDA-TE to improve emotion regulation in healthcare workers, a population that has been particularly emotionally impacted by the COVID-19 pandemic. Methods: In this three-arm, randomized controlled trial (RCT) the study sample will be composed of a minimum of 174 healthcare workers. They will be randomly assigned to a 2-month EMI group (CUIDA-TE APP, n = 58), a 2-month ecological momentary assessment (EMA) only group (MONITOR EMOCIONAL APP, n = 58), or a wait-list control group (no daily monitoring nor intervention, n = 58). CUIDA-TE will provide EMI if EMA reveals emotional problems, poor sleep quality/quantity, burnout, stress, or low perceived self-efficacy when regulating emotions. Depression will be the primary outcome. Secondary outcomes will include emotion regulation, quality of life, and resilience. Treatment acceptance and usability will also be measured. Primary and secondary outcomes will be obtained at pre- and post-intervention measurements, and at the 3-month follow-up for all groups. Discussion: To our knowledge, this is the first RCT that evaluates the efficacy of an APP-based EMI to improve emotion regulation skills in healthcare workers. This type of intervention might ultimately help disseminate treatments and reach a larger number of individuals than traditional face-to-face individual therapies. Trial registration: ClinicalTrial.gov: NCT04958941 Registered 7 Jun 2021. Study status: Participant recruitment has not started.
000117166 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000117166 590__ $$a4.4$$b2022
000117166 592__ $$a1.291$$b2022
000117166 591__ $$aPSYCHIATRY$$b59 / 154 = 0.383$$c2022$$dQ2$$eT2
000117166 593__ $$aPsychiatry and Mental Health$$c2022$$dQ1
000117166 594__ $$a5.4$$b2022
000117166 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000117166 700__ $$0(orcid)0000-0001-9726-3250$$aNavarro-Haro, María Vicenta$$uUniversidad de Zaragoza
000117166 700__ $$aSuso-Ribera, Carlos
000117166 700__ $$0(orcid)0000-0003-4398-4014$$aDíaz-García, Amanda$$uUniversidad de Zaragoza
000117166 700__ $$aZaragoza, Irene
000117166 700__ $$aGarcía-Palacios, Azucena
000117166 7102_ $$14009$$2680$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Person.Eval.Trat.Psicoló.
000117166 773__ $$g22 (2022), 164 [18 pp.]$$pBMC Psychiatry$$tBMC Psychiatry$$x1471-244X
000117166 8564_ $$s2210690$$uhttps://zaguan.unizar.es/record/117166/files/texto_completo.pdf$$yVersión publicada
000117166 8564_ $$s2269659$$uhttps://zaguan.unizar.es/record/117166/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000117166 909CO $$ooai:zaguan.unizar.es:117166$$particulos$$pdriver
000117166 951__ $$a2024-03-18-13:49:35
000117166 980__ $$aARTICLE